Previous close | 12.61 |
Open | 12.60 |
Bid | 15.80 |
Ask | 18.50 |
Strike | 140.00 |
Expiry date | 2024-10-18 |
Day's range | 12.60 - 12.61 |
Contract range | N/A |
Volume | |
Open interest | 51 |
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.